<DOC>
	<DOCNO>NCT02098486</DOCNO>
	<brief_summary>Background aim : The use prophylactic antibiotic endoscopic retrograde cholangiopancreatography ( ERCP ) recommend major international gastroenterological society , especially presence obstruct biliary system . Their use intend decrease eliminate incidence complication follow procedure , namely cholangitis , cholecystitis , septicemia , pancreatitis . However , report concern dosage , duration adopt antibiotic suitable purpose . The aim prospective comparative study compare occurrence rate post-procedural complication , cholangitis , bacteremia septicemia intravenous moxifloxacin ceftriaxone prophylactic use patient bile duct obstruction undergo therapeutic ERCP procedure . Methods : In prospective study , total 160 patient ( calculated IBM SPSS Sample Power , version 3.0 ) bile duct obstruction due variable cause ( bile duct stone , benign malignant stricture , etc ) enrol randomly allocate intravenous moxifloxacin ceftriaxone group , respectively ( use simple randomization program ) . Intravenous moxifloxacin ( 400 mg/day , infuse 60 min ) ceftriaxone ( 2 g/day , dilute 40 cc 5 % dextrose water , infuse 30 min ) give 90 minute ERCP procedure , give patient 3 day patient develops symptom sign cholangitis septicemia .</brief_summary>
	<brief_title>Comparisons Intravenous Ceftriaxone With Intravenous Moxifloxacin ERCP</brief_title>
	<detailed_description />
	<mesh_term>Cholangitis</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>patient bile duct obstruction due variable cause ( bile duct stone , benign malignant stricture , etc ) pregnancy hypersensitivity moxifloxacin and/or ceftriaxone previous antibiotic exposure theophyllin derivative medication within 14 day admission previous history epilepsy previous history endocarditis valvular heart disease</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Bile duct obstruction</keyword>
	<keyword>Cholangitis</keyword>
	<keyword>Moxifloxacin</keyword>
	<keyword>Ceftriaxone</keyword>
	<keyword>Sepsis</keyword>
</DOC>